Real questions, real gaps
What product specialists got wrong, and then got right.
10 real questions from medtech programs on Atrivity, each answered by between 202 and 1,061 sales reps and product specialists. On average, the error rate fell from 57% at the first attempt to 30% at the last.
Clinical and science220 learners
What is a retrospective study?
first attempt56%last attempt21%
What the company gainsReps read and present clinical evidence correctly to physicians
Clinical and science429 learners
What is the fibrocartilage that surrounds the glenoid and increases its stability called?
first attempt66%last attempt33%
What the company gainsReps speak the surgeon's language in shoulder procedures and are trusted in theatre
Product429 learners
Which of these is NOT a purpose of an arthroscopy pump?
first attempt46%last attempt14%
What the company gainsCorrect positioning of capital equipment and fewer misleading claims
Value and access315 learners
How do custom-made contact lenses compare with standard lenses in revenue and profit for the practice?
first attempt51%last attempt24%
What the company gainsA practice-economics pitch that moves eye-care professionals to the premium line
Value and access202 learners
Before a public tender is published, we should...
first attempt56%last attempt29%
What the company gainsEarlier influence on hospital tenders and a higher win rate
Value and access220 learners
How would you argue the cost-effectiveness of our drug-coated balloon?
first attempt62%last attempt36%
What the company gainsValue-based arguments for procurement instead of price discounts
Clinical and science220 learners
Define "statistically significant".
first attempt62%last attempt36%
What the company gainsSounder discussions of trial data with key opinion leaders
Product429 learners
Cutting tools, saw blades and burrs...
first attempt59%last attempt34%
What the company gainsConsumable replacement is protected, and so are surgical outcomes
Product1,061 learners
Does our closed-system drug transfer device have adaptors for 13 mm vials?
first attempt50%last attempt27%
What the company gainsPharmacy objections on compatibility handled on the spot, with no lost deals
Value and access315 learners
How do our lenses protect the eye-care professional's margin?
first attempt61%last attempt47%
What the company gainsA clear channel-protection message that builds partner loyalty
Real questions from client programs, anonymised and translated. Correct answers not shown; metrics unchanged.